Savient Pharmaceuticals Inc (NASDAQ:SVNT)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.

Recs

0
Player Avatar bIlluminati (31.15) Submitted: 7/5/2012 10:21:04 AM : Underperform Start Price: $0.54 SVNT Score: +15.17

Not profitable - prospects poor. Needs to raise money to survive.

Featured Broker Partners


Advertisement